$REVB
Revelation Biosciences, Inc. Common Stock
XNAS
Why is REVB up today? It is at $1.07 (+0.47%), and our scanner flagged it 1 time on unusual volume this month. See the catalyst behind the move, real-time alerts the moment REVB spikes, and full due diligence on REVB — key stats, earnings, dilution and insider activity. Free.
Get free $REVB alerts the moment volume spikes
Our scanner flagged $REVB 1 time in the last 30 days. Create a free account to track $REVB, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $1.07
- Change today
- +0.47%
- Previous close
- $1.07
- 52-week range
- $0.875 – $11.60
- Market cap
- $4M
- Institutional own.
- 7.97%
- Total held
- 12.7%
- Tradeable float
- 3.5M 87% of shares · after 5% insiders + 8% institutions
- Short interest
- 21K ▲ +3% vs prior · as of 2026-07-31
- Short % of float
- 0.6%
- Days to cover
- 1.0d
- Avg daily volume
- 212K
- Exchange
- XNAS
- 5mthin
- 100x
- 15mthin
- 100x
- 1hthin
- 100x
- 1D
- --
Get free REVB + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $REVB moving today?
Here is the latest on REVB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for REVB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystExecutive / Board Change, from the latest SEC filing. Read it →Analyst data via Nasdaq. Not investment advice.
Insiders
Insiders buying6 buys, 1 sells last 3 months (6/8 over 12 months)Show 12 recent transactionsMinimize 12 recent transactions
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carver Jennifer Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 45K | n/a | Aug 17, 26 |
Roper Jess Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 45K | n/a | Aug 17, 26 |
Rolke James Officer | Acquired (grant/award) | +208K 5.2% of company | added 97% | 423K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Acquired (grant/award) | +208K 5.2% of company | n/a | 208K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -208K 5.2% of company | n/a | n/a | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Acquired (grant/award) | +208K 5.2% of company | added 100% | 300K | n/a | Aug 17, 26 |
Chawla Lakhmir S Director | Acquired (grant/award) | +32K 0.8% of company | added 100% | 44K | n/a | Aug 17, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -13K 0.3% of company | sold 13% | 92K | $15K at $1.10 | Apr 30, 26 |
Rolke James Officer | Sold (automatic/other) | -10K 0.3% of company | sold 4.5% | 215K | $11K at $1.13 | Apr 30, 26 |
Zygmont Chester Stanley Iii Officer | Sold (automatic/other) | -13K 0.3% of company | sold 11% | 105K | $22K at $1.65 | Feb 4, 26 |
Rolke James Officer | Sold (automatic/other) | -9K 0.2% of company | sold 3.7% | 225K | $16K at $1.86 | Feb 3, 26 |
Carver Jennifer Director | Sold (automatic/other) | -2K 0.04% of company | sold 12% | 13K | $3K at $1.87 | Feb 3, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Dilution watch
Active shelfRecent share offering + active shelf on file — the company raised capital and can raise more. If $REVB runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 4,272,500 new shares · About $14.7M in size
- About $14.7M in size
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$REVB Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$REVB Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
REVB stock FAQ
Why is $REVB moving today?
Here is the latest on REVB from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for REVB today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the REVB stock price today?
REVB last traded at $1.07, up 0.47% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live REVB alerts?
The REVB Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged REVB 1 time in the last 30 days.
What exchange is REVB on?
REVB (Revelation Biosciences, Inc. Common Stock) trades on XNAS, with a market cap of about $4M.
Is REVB good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge REVB for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.